Trials / Completed
CompletedNCT02201849
A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults
A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral ALKS 8700 in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the safety, tolerability, and pharmacokinetics of ALKS 8700, a monomethyl fumerate (MMF) molecule.
Detailed description
This study record was previously posted/updated by Alkermes, Inc. As of 29 Oct 2019, the sponsorship of the trial was transferred to Biogen along with responsibility for subsequent updates to the record.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Study Drug | |
| DRUG | Active Control | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-07-28
- Last updated
- 2019-11-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02201849. Inclusion in this directory is not an endorsement.